UB Paderborn / Katalog / Suche / in CDI

Motixafortide and Pembrolizumab Combined to Nanoliposomal Irinotecan, Fluorouracil, and Folinic Acid in Metastatic Pancreatic Cancer: The COMBAT/KEYNOTE-202 Trial

Clinical cancer research, 2021-09, Vol.27 (18), p.5020-5027

2021

Link zum Volltext

Verfügbarkeit prüfen

Novel Molecular Characterization of Colorectal Primary Tumors Based on miRNAs

Cancers, 2019-03, Vol.11 (3), p.346

2019

Link zum Volltext

Verfügbarkeit prüfen

Phase I/II Trial to Evaluate the Efficacy and Safety of Nanoparticle Albumin-Bound Paclitaxel in Combination With Gemcitabine in Patients With Pancreatic Cancer and an ECOG Performance Status of 2

Journal of clinical oncology, 2019-01, Vol.37 (3), p.230-238

2019

Link zum Volltext

Verfügbarkeit prüfen

Relationship Between Sarcopenia and Frailty in a Spanish Cancer in the Elderly Unit: The ONCOSARCO Project

Journal of the American Medical Directors Association, 2016-08, Vol.17 (8), p.760-761

2016

Link zum Volltext

Verfügbarkeit prüfen

Can we avoid the toxicity of chemotherapy in elderly cancer patients?

Critical reviews in oncology/hematology, 2018-11, Vol.131, p.16-23

2018

Link zum Volltext

Verfügbarkeit prüfen

Where Are We Headed With Research in Frail Elderly Patients With Cancer?

Journal of clinical oncology, 2016-11, Vol.34 (33), p.4049-4050

2016

Link zum Volltext

Verfügbarkeit prüfen

Integrative multi-platform meta-analysis of gene expression profiles in pancreatic ductal adenocarcinoma patients for identifying novel diagnostic biomarkers

PloS one, 2018-04, Vol.13 (4), p.e0194844-e0194844

2018

Link zum Volltext

Verfügbarkeit prüfen

Use of geriatric assessment and screening tools of frailty in elderly patients with prostate cancer. Review

The aging male, 2017-06, Vol.20 (2), p.102-109

2017

Link zum Volltext

Verfügbarkeit prüfen

Phase I/II trial of sequential treatment of nab-paclitaxel in combination with gemcitabine followed by modified FOLFOX chemotherapy in patients with untreated metastatic exocrine pancreatic cancer: Phase I results

European journal of cancer (1990), 2020-11, Vol.139, p.51-58

2020

Link zum Volltext

Verfügbarkeit prüfen

CASP8 D302H polymorphism delays the age of onset of breast cancer in BRCA1 and BRCA2 carriers

Breast cancer research and treatment, 2010, Vol.119 (1), p.87-93

2010

Link zum Volltext

Verfügbarkeit prüfen

Regorafenib plus modified FOLFOX6 as first-line treatment of metastatic colorectal cancer: A phase II trial

European journal of cancer (1990), 2015-05, Vol.51 (8), p.942-949

2015

Link zum Volltext

Verfügbarkeit prüfen

Understanding the molecular-based mechanism of action of the tyrosine kinase inhibitor: sunitinib

Anti-cancer drugs, 2010-01, Vol.21 Suppl 1 (Supplement 1), p.S3-S11

2010

Link zum Volltext

Verfügbarkeit prüfen

Broad BRCA1 and BRCA2 mutational spectrum and high incidence of recurrent and novel mutations in the eastern Spain population

Breast cancer research and treatment, 2010-05, Vol.121 (1), p.257-260

2010

Link zum Volltext

Verfügbarkeit prüfen

Update on the management of elderly patients with colorectal cancer

Clinical & translational oncology, 2024, Vol.26 (1), p.69-84

2024

Link zum Volltext

Verfügbarkeit prüfen

A first-in-human phase 1/2 study of FGF401 and combination of FGF401 with spartalizumab in patients with hepatocellular carcinoma or biomarker-selected solid tumors

Journal of experimental & clinical cancer research, 2022-06, Vol.41 (1), p.189-189, Article 189

2022

Link zum Volltext

Verfügbarkeit prüfen

Overvaluation of the vulnerable elders survey-13 as a screening tool for vulnerability

Journal of clinical oncology, 2011-08, Vol.29 (23), p.3201-3202

2011

Link zum Volltext

Verfügbarkeit prüfen

Current controversies in the management of metastatic colorectal cancer

Cancer Chemotherapy and Pharmacology, 2015-10, Vol.76 (4), p.659-677

2015

Link zum Volltext

Verfügbarkeit prüfen

The Int7G24A variant of transforming growth factor-beta receptor type I is a risk factor for colorectal cancer in the male Spanish population: a case-control study

BMC cancer, 2009-11, Vol.9 (1), p.406-406, Article 406

2009

Link zum Volltext

Verfügbarkeit prüfen

The TGFBR16A allele is not associated with susceptibility to colorectal cancer in a Spanish population: a case-control study

BMC cancer, 2009-06, Vol.9 (1), p.193-193, Article 193

2009

Link zum Volltext

Verfügbarkeit prüfen

Delphi consensus of an expert committee in oncogeriatrics regarding comprehensive geriatric assessment in seniors with cancer in Spain

Journal of geriatric oncology, 2018-07, Vol.9 (4), p.337-345

2018

Link zum Volltext

Verfügbarkeit prüfen

Menü

Weitere Dienste

Einstellungen

Motixafortide and Pembrolizumab Combined to Nanoliposomal Irinotecan, Fluorouracil, and Folinic Acid in Metastatic Pancreatic Cancer: The COMBAT/KEYNOTE-202 Trial

Novel Molecular Characterization of Colorectal Primary Tumors Based on miRNAs

Benefit of Surveillance for Pancreatic Cancer in High-Risk Individuals: Outcome of Long-Term Prospective Follow-Up Studies From Three European Expert Centers

Phase I/II Trial to Evaluate the Efficacy and Safety of Nanoparticle Albumin-Bound Paclitaxel in Combination With Gemcitabine in Patients With Pancreatic Cancer and an ECOG Performance Status of 2

Relationship Between Sarcopenia and Frailty in a Spanish Cancer in the Elderly Unit: The ONCOSARCO Project

Can we avoid the toxicity of chemotherapy in elderly cancer patients?

Where Are We Headed With Research in Frail Elderly Patients With Cancer?

Integrative multi-platform meta-analysis of gene expression profiles in pancreatic ductal adenocarcinoma patients for identifying novel diagnostic biomarkers

Use of geriatric assessment and screening tools of frailty in elderly patients with prostate cancer. Review

Phase I/II trial of sequential treatment of nab-paclitaxel in combination with gemcitabine followed by modified FOLFOX chemotherapy in patients with untreated metastatic exocrine pancreatic cancer: Phase I results

CASP8 D302H polymorphism delays the age of onset of breast cancer in BRCA1 and BRCA2 carriers

Regorafenib plus modified FOLFOX6 as first-line treatment of metastatic colorectal cancer: A phase II trial

Understanding the molecular-based mechanism of action of the tyrosine kinase inhibitor: sunitinib

Broad BRCA1 and BRCA2 mutational spectrum and high incidence of recurrent and novel mutations in the eastern Spain population

Update on the management of elderly patients with colorectal cancer

A first-in-human phase 1/2 study of FGF401 and combination of FGF401 with spartalizumab in patients with hepatocellular carcinoma or biomarker-selected solid tumors

Phase I, multicenter, open-label study of intravenous VCN-01 oncolytic adenovirus with or without nab-paclitaxel plus gemcitabine in patients with advanced solid tumors

Overvaluation of the vulnerable elders survey-13 as a screening tool for vulnerability

Current controversies in the management of metastatic colorectal cancer

The Int7G24A variant of transforming growth factor-beta receptor type I is a risk factor for colorectal cancer in the male Spanish population: a case-control study

The TGFBR16A allele is not associated with susceptibility to colorectal cancer in a Spanish population: a case-control study

Evolution of RAS Mutations in Cell-Free DNA of Patients with Tissue RAS Wild-Type Metastatic Colorectal Cancer Receiving First-Line Treatment: The PERSEIDA Study

Delphi consensus of an expert committee in oncogeriatrics regarding comprehensive geriatric assessment in seniors with cancer in Spain

FOLFOXIRI plus bevacizumab versus FOLFOX plus bevacizumab for patients with metastatic colorectal cancer and ≥3 circulating tumour cells: the randomised phase III VISNÚ-1 trial

Gemcitabine–erlotinib versus gemcitabine–erlotinib–capecitabine in the first-line treatment of patients with metastatic pancreatic cancer: Efficacy and safety results of a phase IIb randomised study from the Spanish TTD Collaborative Group

Suchergebnisse filtern